Kangenbei: Ginkgo biloba extract has been approved the EU CEP certificate
-
Last Update: 2014-04-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Wang Ruwei, executive vice president and director of Kangenbei [- 0.69% capital research report] (600572 SH), said at the investor exchange meeting that the company's Ginkgo biloba extract received the CEP certificate issued by the European Union in March this year After passing the on-site certification of cGMP, it can activate the EU sales of pharmaceutical raw materials Wang Ruwei said that the company's Ginkgo biloba extract is currently exported to the European Union as a chemical raw material and intermediate After cGMP certification, it can be exported and sold as a pharmaceutical raw material, which will be improved in the scope of use and product pricing On the other hand, obtaining cGMP also helps to enhance the brand effect of the company's ginkgo leaf industrial base Ginkgo biloba extract is another major source of revenue for Kangenbei in addition to drug sales Its subsidiary, Yunnan Xitao green Pharmaceutical Co., Ltd., has one of the largest extraction production bases in Yunnan Province, with an annual processing capacity of 6000 tons of Chinese herbal medicines and a production capacity of over 100 tons of Ginkgo biloba extract.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
